1,2:3,4-Di-O-cyclohexylidene-5-O-methyl-L-chiro-inositol (CAS 6848-53-9)

1,2:3,4-Di-O-cyclohexylidene-5-O-methyl-L-chiro-inositol, also known as DCMC, has emerged as a vital tool in biochemical research, particularly in studies focusing on inositol signaling pathways and cellular processes. As a derivative of chiro-inositol, DCMC plays a crucial role in modulating various cellular functions through its interactions with inositol-related proteins and enzymes. One of the primary mechanisms of action of DCMC involves its ability to act as an analog of chiro-inositol, thereby influencing inositol-dependent signaling pathways. Research suggests that DCMC can competitively inhibit the binding of endogenous chiro-inositol to specific inositol-binding proteins, consequently altering downstream signaling events mediated by these proteins. Additionally, DCMC has been utilized as a chemical probe in elucidating the physiological roles of inositol derivatives and their involvement in cellular processes such as cell growth, differentiation, and intracellular signaling. Furthermore, DCMC has been employed in structural studies to investigate the binding interactions between inositol derivatives and their target proteins, providing valuable insights into the molecular mechanisms underlying inositol signaling. Overall, DCMC serves as a valuable tool in biochemical research, offering opportunities to explore the complex roles of inositol derivatives in cellular physiology and pathology.